4'-O-substitutions determine selectivity of aminoglycoside antibiotics

Autor: Venki Ramakrishnan, Ng Chyan Leong, Déborah Perez-Fernandez, Erik C. Böttger, Rashid Akbergenov, Pia Thommes, Stefan Duscha, Pietro Freihofer, Kathrin Lang, Iwona Kudyba, Rashmi Patak, Heithem Boukari, Andrea Vasella, Dmitri Shcherbakov, Swapna Vaddi, Martin Meyer, Srinivas Reddy Dubbaka, Tanja Matt
Přispěvatelé: University of Zurich, Vasella, Andrea
Rok vydání: 2013
Předmět:
Male
Staphylococcus aureus
medicine.drug_class
Antibiotics
Molecular Sequence Data
Mycobacterium smegmatis
General Physics and Astronomy
610 Medicine & health
1600 General Chemistry
Microbial Sensitivity Tests
Bioinformatics
Crystallography
X-Ray

Ribosome
General Biochemistry
Genetics and Molecular Biology

Article
Cell-free system
Inhibitory Concentration 50
Mice
1300 General Biochemistry
Genetics and Molecular Biology

RNA
Ribosomal
16S

Sepsis
medicine
Escherichia coli
Animals
Humans
Drug Interactions
Multidisciplinary
Base Sequence
Cell-Free System
Chemistry
10179 Institute of Medical Microbiology
Aminoglycoside
RNA
General Chemistry
Ribosomal RNA
3100 General Physics and Astronomy
3. Good health
Anti-Bacterial Agents
Cytosol
Disease Models
Animal

Aminoglycosides
Biochemistry
Protein Biosynthesis
570 Life sciences
biology
Nucleic Acid Conformation
Antibacterial activity
Ribosomes
Zdroj: Nature Communications
Nature Communications, 5
'Nature Communications ', vol: 5, pages: 3112-1-3112-11 (2014)
ISSN: 2041-1723
Popis: Clinical use of 2-deoxystreptamine aminoglycoside antibiotics, which target the bacterial ribosome, is compromised by adverse effects related to limited drug selectivity. Here we present a series of 4′,6′-O-acetal and 4′-O-ether modifications on glucopyranosyl ring I of aminoglycosides. Chemical modifications were guided by measuring interactions between the compounds synthesized and ribosomes harbouring single point mutations in the drug-binding site, resulting in aminoglycosides that interact poorly with the drug-binding pocket of eukaryotic mitochondrial or cytosolic ribosomes. Yet, these compounds largely retain their inhibitory activity for bacterial ribosomes and show antibacterial activity. Our data indicate that 4′-O-substituted aminoglycosides possess increased selectivity towards bacterial ribosomes and little activity for any of the human drug-binding pockets.
Aminoglycoside antibiotics target the ribosome but their limited selectivity for the bacterial ribosome can cause side effects in humans. Here, the authors synthesize 4′-O-ether or 4′,6′-O-acetal modifications and show that these compounds possess increased selectivity against bacterial ribosomes.
Databáze: OpenAIRE